ZYVERSA THERAPEUTICS, INC. Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price of $15.25 per share as of 2023-05-24, per its 10-K filed 2024-03-25.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 · last filed 2024-03-25
- 2023-05-24: Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price $15.25; Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price as first filed $0.44.
- 2023-03-10: Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price $79.10; Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price as first filed $2.26.
- 2023-01-27: Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price $73.85; Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price as first filed $2.11.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price | Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price as first filed |
|---|---|---|
| 2023-05-24 | $15.25 10-K · filed 2024-03-25 | $0.44 10-Q · filed 2023-08-21 |
| 2023-03-10 | $79.10 10-K · filed 2024-03-25 | $2.26 10-Q · filed 2023-05-12 |
| 2023-01-27 | $73.85 10-K · filed 2024-03-25 | $2.11 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |